Most fertility patients offered treatments that ‘don't work'
Most fertility patients are being offered treatments that are not proven to increase the chance of success, a report has said.
Almost three quarters of fertility patients are being offered unnecessary add-on treatments, nearly all of which 'are not proven to increase the chance of having a baby', the fertility regulator has said.
The report by the Human Fertilisation and Embryology Authority (HFEA) into the experiences of 1,500 patients in the UK also found that 51 per cent of those seeking donor sperm received it from overseas.
Most patients cited increased choice and more information about the donor as the reasons why they chose foreign sperm.
The HFEA said that in the UK a donor's sperm can only be used to create up to 10 families, but the 10-family limit does not apply abroad.
The report also highlighted long waits for some patients – particularly those seeking NHS care.
Around a quarter of patients had used donor eggs, sperm or embryos in treatment.
Of the 73 per cent who were offered 'add-on treatments', only 52 per cent had the effectiveness explained to them, while 37 per cent were told about the risks.
The report found add-on treatments such as the use of endometrial scratching – when the lining of the womb is scratched before an embryo is implanted – had decreased last year, but was still being offered.
It also found the use of a so-called 'emerging technology' known as pre-implantation genetic testing for aneuploidy – the checking of embryos for abnormalities in the number of chromosomes – increased to 13 per cent in 2024, even though the HFEA said there is 'insufficient evidence' of its effectiveness at improving the chance of pregnancy.
Julia Chain, chairman of the HFEA, said: 'It's disappointing to see a significant number of patients are still using add-ons and emerging technologies, and particularly disappointing that only half of patients had the effectiveness explained to them, let alone the risks.
'We regularly remind clinics that, according to our Code of Practice, they must give patients a clear idea of what any treatment add-on involves, how likely it is to increase their chance of a successful pregnancy, cost, risks, and link to our public ratings system.
'We will continue to remind clinics about improving clarity and communication for patients.'
The report also found that most patients began treatment seven months to a year after first seeing their GP about their fertility problems. But 16 per cent of patients waited over two years.
NHS-funded patients reported longer wait times in starting treatment compared to those who paid privately.
Some 53 per cent of private patients started treatment within a year compared to 35 per cent of NHS patients.
The regulator said that its data shows that the number of NHS-funded treatment cycles is falling, and stood at just 27 per cent in 2022.
Ms Chain said the regulator was also 'concerned that NHS-funded patients are waiting longer than self-funded patients to start fertility treatment'.
'The delays faced by NHS patients highlight ongoing issues relating to the provision of specialist care for women,' she said.
'As part of our response to the Government's 10-year plan, we want to see a much shorter time for patients to begin fertility treatment once they have received advice or a referral from their GP.'
A Department of Health spokesman said: 'It is unacceptable fertility patients are being offered unnecessary treatments that will not help them in their goal of becoming parents.
'We are working to improve access to NHS fertility services for all who need it.
'We are also currently considering advice from the HFEA about priorities for law reform covering their regulatory powers, including their potential role in digital clinics.'
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Mom Forced to Wait 2-Plus Years for 'Urgent' Ovarian Cyst Surgery, Says There's 'No End Point'
Tracy Meechan, a 41-year-old Scottish woman, said she has now waited over two years for surgery to have a large ovarian cyst removed Meechan told the BBC that her cyst causes her so much pain that she cannot fully bend over and needs help from her children just to put on her socks and shoes She said she feels "forgotten" after spending 100 weeks on a waiting listA woman says she has now waited 100 weeks for ovarian cyst surgery, although she was placed on an "urgent" list for the procedure. Tracey Meechan told the BBC that she feels "forgotten" after spending two years on a waiting list for NHS, the United Kingdom's publicly-funded healthcare system. The cyst pain is so intense that she is unable to fully bend over, and needs her children to help her put on her socks and shoes, and has her husband take care of household tasks. The 41-year-old, who is from West Dunbartonshire, Scotland, worked as a home carer before she "signed off work" in January because of the pain. She told the BBC she feels the effects of her cyst every day that she spends on the wait list. "I can't live my life to the fullest. I can't do the activities I want to do with my kids," she said. "I can't do the job that I love." Meechan first saw her doctor about the cyst in 2021. After the visit, she waited a year to see a gynecologist for the condition, and was put on the "urgent" list for surgery after the gynecologist found that the cyst had grown over the course of six months. Although she initially assumed the surgery appointment would take place "relatively soon" because she was asked about any upcoming holiday plans, Meechan said she still has not been contacted about her cyst removal. She told the BBC, "About a year ago I was advised by the GP to try to get in touch with the gynecology secretary myself and I have been doing that on a regular basis letting them know I am still here and still waiting." Meechan also claimed that the NHS continues to move the timeline of her surgery whenever she calls. She said, "It's another couple of months, or they are working on the routine list, or working on the long waiters." "I was told at week 92 that they were working on women round about week 98-99, so it should be another couple of months," Meechan told the BBC. "When I did get to week 99, I called up because I wanted to keep my employer up to date. I was told they couldn't give me a date and still nothing is fixed yet." Meechan even considered getting the cyst removed through private health care, but the £8,000 price tag (which comes out to $10,806) made the option unaffordable. While waiting for the surgery, she said her mental health has "declined," telling the BBC, "This has been years and the symptoms have worsened. It's impacted my life, my personal life and my family." Meechan feels there is "no end point," telling the outlet, "It's a drudge," and adding, "there is only so much pain relief I can take and still try to be a mother to my children." A spokesperson for NHS Greater Glasgow and Clyde told the BBC that they "apologize" to Meechan "and to anyone who has faced longer waiting times than expected." Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. "We recognize the distress this can cause," they said, adding, "We are prioritizing patients based on clinical urgency to ensure those with the most serious conditions are seen as quickly as possible and are taking action to improve wait times." The BBC reports that wait times as long as Meechan's were "rare" before the COVID-19 pandemic. Now, nearly 25% of the entire NHS non-urgent care inpatient wait list is made up of waits longer than one year. The outlet reports that the NHS's gynecology wait list had 324 waits of more than three years. Read the original article on People
Yahoo
6 hours ago
- Yahoo
The NHS teams mopping up sloppy foreign surgery
As consultant plastic surgeon at Manchester's busy Wythenshawe Hospital, a typical day for Dr Fouzia Choukairi involves spending hours in the operating theatre reconstructing someone's limbs following a terrible traffic accident. But every few weeks, she or an on-call colleague will be buzzed to the A&E department where, among the melee of broken bones, bleeding gashes and limping children, she will face a different challenge: performing sometimes life-saving treatment on a patient who has returned from overseas having had cosmetic surgery. 'They may have had tummy tucks [abdominoplasty] or breast implants,' she explains. 'But then they will have got a wound or implant infection after flying home, and they may be very, very sick. They can need life-saving treatment, and it can involve a huge team – not just the A&E staff but surgeons, microbiologists, intensive care specialists, anaesthetists, nurses, wound care and rehabilitation staff. 'The patients are often very grateful, and sometimes verbally regret having had the surgery,' she adds. 'I guess you're not going to stop people from going abroad for surgery, but we do feel patients are not well-informed or well-equipped to deal with any complications.' For years, NHS staff have voiced concern at having to 'mop up the mess' caused by foreign cosmetic procedures mostly undertaken in Turkey, considered the medical tourism capital of the world. All too often, they say, the promise of cheap liposuction, BBLs (Brazilian butt lifts), facelifts and hair transplants promoted online and sold as part of 'luxury holiday packages' can result instead in infections, blood clots, sepsis, deformities and even death. Now, however, they are warning of a new issue – that of antibiotic-resistant superbugs being brought back from overseas into UK hospitals by these patients. 'Turkey is a gateway between East and West,' explains Dr Choukairi, who also works at Hale Private Clinic in Manchester. 'You have a huge mixture of people from all over the world flowing through these hospitals, airports and hotels. The patient would have travelled back on a plane, perhaps with open wounds or dressings, and they can pick up multi-resistant bugs at any of these steps. 'Usually, antibiotics can target infections very efficiently but if you're faced with a multi-resistant bug or an unusual bug, you have to throw broad-spectrum antibiotics at it, which are not as efficient and may take longer to clear it. 'If the person is very sick and requires intensive care, this is the worst-case scenario. And, of course, there is a small risk these bugs can be passed onto the person in the next bed if, say, they are immunosuppressed or also have open wounds.' Her concern over antibiotic-resistant bugs being brought into the NHS is not in isolation. At the recent Royal College of Nursing annual conference in Liverpool, NHS nurses spoke of 'horrific' wounds and infections seen in patients following overseas surgery. Nykoma Hamilton, an infection control nurse in Fife, Scotland, said patients were increasingly infected with bacteria resistant to even the strongest antibiotics – a group of drugs called carbapenems, which are used as a last resort when all other antibiotics have proved ineffective. Describing the superbugs as the 'absolute granddaddy of resistance', she told the conference that NHS hospitals and clinics in her area had recorded a 'near 30 per cent' increase in carbapenem-resistant bacteria in recent years. 'Our concerns relate to the fact that a lot of people are colonised with a lot of extensively drug-resistant organisms,' she said. It is an alarming development. The World Health Organisation has previously warned that the world is heading for a 'post-antibiotic' era, with figures from the UK Health Security Agency showing the number of antibiotic-resistant infections across the UK has grown by seven per cent in recent years, up from around 62,000 in 2019 to nearly 67,000 in 2023. Doctors are also warning the risk of such infections is only likely to grow due to the numbers having foreign cosmetic surgery rising each year. Last year, an estimated 150,000 Brits travelled to Turkey for beauty tweaks – with some saying the rise of NHS weight loss drugs such as Wegovy and Mounjaro have fuelled the trend. 'Massive weight loss can result in loose skin on the face, tummy, arms and thighs,' says Dr Mo Akhavani, consultant plastic surgeon at the Royal Free Hospital in Hampstead, London, who regularly deals with post-operative complications. 'People understandably don't want to live with this, but the NHS has finite resources and, although the health benefits are well known, the procedure is deemed low priority, so people go overseas for cheap surgery. He adds: 'The surgeons in Turkey are often very good and the vast majority of operations go right, but the aftercare can be a problem.' Dr Akhavani, who also works at London's Plastic Surgery Group, says he has helped a 'growing' number of patients, especially since Covid. In 2023, figures from the British Association of Aesthetic Plastic Surgeons (BAAPS) also showed a 94 per cent rise in three years of people needing corrective surgery on the NHS – with the total cost to the taxpayer being around £4.8 million. 'There are factors leading to this increased risk,' he tells The Telegraph. 'First, if a patient has had huge weight loss, they may well have had other conditions such as diabetes and high blood pressure, which can cause complications. 'Then they may have multi-site surgery, which UK doctors wouldn't advise doing, where loose or fat skin is removed from several areas, and perhaps combined with breast implants or other procedures, meaning longer on the operating table and an increased risk of blood clots and even death. 'Thirdly, patients must also refrain from getting on a flight for six weeks post-surgery but they often fly straight home, which can lead to wound-healing problems.' Dr Akhavani adds, 'We see them in A&E sometimes with gaping wounds and pus pouring out. They need antibiotic drips, then can be taken into theatre to wash out the infection, and may end up in intensive care for weeks. Often we are giving life-saving treatment but we will not correct deformities, such as removed implants, from the emergency surgery. This is the NHS and that ultimately means taxpayers' money needs to be protected.' In previous years, both the BAAPS and the British Medical Association (BMA) have highlighted the risks involved with the $4.5 billion (£3.5 billion) global industry. These include the lack of proper consultations and risk assessments, paperwork in a foreign language, and a financial commitment to the surgery prior to travel. With surgery tied to luxury packages, patients may often have top hotels and transport, but no health monitoring post-surgery. One doctor told The Telegraph in graphic detail of a patient who had had a BBL, but then flew home, with the fat seeping out of the wound while on the plane. The patient needed three separate surgeries to repair it and was left 'traumatised'. A second nurse at the recent RCN conference recounted a young woman who had skin removal in Turkey, then returned to the UK with a large thigh wound only loosely held together with stitches. She also had dying tissue and sepsis. 'All she told me about was how fantastic the hotel was after she'd had her surgery and that they took her back to a posh car,' she said. 'But there was no blood pressure testing, no aftercare for this woman at all. In fact, I'm surprised she made it back on the flight. It's really scary.' In 2022, a mother from Berkshire, known only as Carrie, contracted a flesh-eating virus after having a £4,500 tummy tuck in Istanbul. Four days after returning to the UK, she was rushed to hospital and treated for sepsis and organ failure. The same year, Pinky Jolley required treatment in two Liverpool hospitals following botched £2,100 gastric sleeve surgery abroad that left her with multiple infections, sepsis and a permanently damaged oesophagus and stomach. She was left needing a feeding tube and largely bed bound. The growing probability of superbugs has also been highlighted, with the BAAPS saying: 'Some people are returning with multi-resistant bacteria that are hard to treat and may infect other people.' In November 2024, following a spate of deaths of women who had flown to Turkey for BBLs, these concerns reached the top of government, with Wes Streeting, the Health Secretary, urging people to 'think very carefully' before going overseas for surgery. Back on the NHS front line, however, doctors see little chance of this happening. Dr Amer Hussain is a plastic surgeon at Leeds Teaching Hospitals. His work involves reconstructing breasts for women who have had mastectomies following cancer. But at times he has to postpone such operations due to hospital bed shortages caused by beds occupied by those in need of urgent care. 'Patients come in following Turkey operations with infected breast implants,' he says. 'They have redness, fever or discharge from the wound and the implant needs to be removed. We are also seeing bad infections – with the bugs not even necessarily endemic to Turkey, meaning they are coming from elsewhere in the world.' Like all doctors, he is aware of the strain on the NHS. 'I do major breast reconstruction, often for cancer patients, and the backlog of these operations due to Covid has still not been reduced,' he explains. 'So doing these emergency surgeries does have an impact on waiting times, beds and theatre time. 'The problem is that this is high-volume surgery abroad, without checks and balances, and the NHS is being forced to step in. But it is frustrating, because at the end of the day, where resources are precious, they should be for patients who need them the most.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Medscape
10 hours ago
- Medscape
UK Cancer Deaths Drop 22% in 50 Years Despite Rising Cases
Cancer death rates in the UK have fallen by 22% over the past 50 years. However, diagnoses have risen by almost half, according to a new analysis by Cancer Research UK (CRUK). The Cancer in the UK Report 2025 provides the first 50 years of UK-wide data on cancer mortality and cases. Death rates fell from around 328 per 100,000 people in 1973 to around 252 per 100,000 in 2023. CRUK described the findings as 'profound'. The charity said improvements in diagnosis, treatment, and smoking reduction had helped drive the decline. People today are twice as likely to survive their disease for at least 10 years compared to 50 years ago. Survival rates improved from one in four people in the early 1970s to one in two today. Rising Incidence Despite Progress Cancer incidence rates increased sharply by 47% during the same period. Cases rose from around 413 to 607 per 100,000 people. However, the charity noted that because of the UK's growing and ageing population, actual numbers continue to rise. Nearly 1100 new cases are diagnosed daily, with more than 460 deaths each day. This occurs despite significant progress in prevention, detection, diagnosis, and treatment. CRUK called on the government to ensure that its upcoming National Cancer Plan for England is 'ambitious and fully funded'. Early Diagnosis Rates Stagnant Research into improving screening programmes, tests, and drugs helped reduce death rates. Policy action on smoking reduced rates for cancers with poor survival outcomes. Lung cancer mortality rates decreased from 80.9 per 100,000 people in 1971-1973 to 49.8 in 2021-2023. Bowel cancer rates fell from 48.0 to 26.3, whilst breast cancer dropped from 30.7 to 16.9. However, pancreatic cancer rates remained stable at around 15 per 100,000 people. Some cancers showed increases, including prostate cancer from 13.3 to 18.3 and oesophageal cancer from 9.2 to 12.0. Just over half of cancers (54%) were diagnosed at an early stage in England, the report found. This proportion has not changed for almost a decade. Around half of all new cancer diagnoses occur in people aged 70 and over. However, incidence rates are rising fastest in younger people, with a 23% increase in people aged 20 to 49 since the early 1990s. Screening Programmes Save Lives Three cancer screening programmes save around 5000 lives every year across the UK, according to CRUK. Smoking remains the biggest cause of cancer in the UK. It accounts for around a fifth of all cancer deaths each year. Around one in 20 UK cancer deaths are now linked to being overweight or obese. Michelle Mitchell, CRUK's chief executive, welcomed the reduced death rates and doubled survival rates. However, she stressed that too many cases are diagnosed at a late stage. "If we want to change that, we need bold action from the UK government," Mitchell said. Professor Peter Johnson, NHS national clinical director for cancer, highlighted recent innovations. These include lung cancer screening in car parks and AI technology to spot skin cancer. Mitchell urged that the upcoming National Cancer Plan for England must improve survival and transform services. She said the plan "could save countless lives across England and ensure people affected by cancer live longer, better lives". CRUK has also published devolved nation summaries of its findings for Scotland, Wales, and Northern Ireland.
